PAF receptor structure: A hypothesis

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Lipids

• Publication date

  1991-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02536523PMID 1668112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonates.

  1991cited by this paper
• New hypothesis on the conformation of the PAF-receptor from studies on the geometry of selected platelet-activating factor-antagonists.

  1991cited by this paper
• PAF-receptor. III. Conformational and electronic properties of PAF-like agonists and antagonists.

  1991cited by this paper
• PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonists.

  1989cited by this paper
• PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.

  1989cited by this paper
• Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres.

  1988cited by this paper
• Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity.

  1987cited by this paper
• Platelet-Activating Factor Binding to Specific Cell Membrane Receptors

  1987cited by this paper
• Conformational Properties of the PAF-Acether Receptor on Platelets Based on Structure—Activity Studies

  1987cited by this paper
• Perspectives in platelet-activating factor research.

  1987cited by this paper
• Platelet-Activating Factor and Related Lipid Mediators

  1987influential reference
• Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.

  1986cited by this paper
• Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety.

  1986cited by this paper
• PAF-acether specific binding sites: 2. Design of specific antagonists

  1986cited by this paper
• PAF-acether specific binding sites: 1. quantitative SAR study of PAF-acether isosteres

  1986cited by this paper
• Structural analogs of alkylacetylglycerophosphocholine inhibitory behavior on platelet activation.

  1985cited by this paper
• Platelet-activating factor and structurally related ether-lipids

  1984cited by this paper
• Platelet-activating factor and structurally related ether lipids: edited by J. Benveniste and B. Arnoux, Elsevier Science Publishers, 1983. $73.00, Dfl. 190 (xviii + 370 pages) ISBN 0 444 80552 4

  1984cited by this paper
• New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures.

  1981cited by this paper
• Structural analogs of platelet-activating factor (PAF-acether).

  1981cited by this paper
• Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils.

  1981cited by this paper

• Synthesis of New Trisubstituted 4‐Aminopiperidines as PAF‐Receptor Antagonists

  2008cites this paper
• Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.

  2006cites this paper
• Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction.

  2001cites this paper
• A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins.

  2001cites this paper
• Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes.

  1999cites this paper
• The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.

  1998cites this paper
• In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study.

  1998cites this paper
• Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines.

  1997cites this paper
• Achievements and prospects in the creation of antiaggregative drugs (Review)

  1997cites this paper
• A pharmacophore for high affinity PAF antagonists. II. Hydrophobicity study using the molecular lipophilicity potential.

  1997cites this paper
• Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity.

  1996cites this paper
• A pharmacophore for high affinity PAF antagonists. I. Electronic model using molecular electrostatic potential.

  1996cites this paper
• Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SAR.

  1996cites this paper
• Evaluation of some benzyl and benzylidene monosubstituted gamma-butyrolactones and tetrahydrofurans as platelet activating factor antagonist agents.

  1995cites this paper
• Platelet-activating factor antagonists.

  1994cites this paper
• Preclinical studies with platelet-activating factor antagonists in models of septic shock.

  1993cites this paper
• Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines.

  1993cites this paper
• A Monte Carlo pharmacophore generation procedure: Application to the human PAF receptor

  1993cites this paper
• PAF receptor and “cache-oreilles” effect. Simple PAF antagonists

  1991cites this paper